首页> 美国卫生研究院文献>Cardiovascular Diseases >Coronary Interventions before Liver Transplantation Might Not Avert Postoperative Cardiovascular Events
【2h】

Coronary Interventions before Liver Transplantation Might Not Avert Postoperative Cardiovascular Events

机译:肝移植前的冠状动脉介入治疗可能不会避免术后心血管事件

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Percutaneous coronary intervention and coronary artery bypass grafting may be performed before orthotopic liver transplantation (OLT) to try to improve the condition of patients who have severe ischemic heart disease. However, data supporting improved outcomes are lacking.We reviewed the medical records of 2,010 patients who underwent OLT at our hospital from 2000 through 2010. The 51 patients who underwent coronary artery angiography within 6 months of transplantation were included in this study: 28 had mild coronary artery disease, 10 had moderate disease, and 13 had severe disease. We compared all-cause and cardiac-cause mortality rates.We found a significant difference in cardiac deaths between the groups (P <0.001), but none in all-cause death (P=0.624). Of the 10 patients who had moderate coronary artery disease, one underwent pre-transplant coronary artery bypass grafting. Of 13 patients with severe disease, 3 underwent percutaneous coronary intervention, and 6 underwent coronary artery bypass grafting. Overall, 50% of patients who underwent either intervention died of cardiac-related causes, whereas no patient died of a cardiac-related cause after undergoing neither intervention (P <0.0001).We conclude that, despite coronary intervention, mortality rates remain high in OLT patients who have severe coronary artery disease.
机译:可以在原位肝移植(OLT)之前进行经皮冠状动脉介入治疗和冠状动脉搭桥术,以改善患有严重缺血性心脏病的患者的状况。但是,缺乏支持改善结局的数据。我们回顾了2000年至2010年在我院接受OLT的2010例患者的病历。该研究包括51例在移植后6个月内进行了冠状动脉造影的患者:28例为轻度冠心病,10例为中度疾病,13例为严重疾病。我们比较了全因和心脏原因死亡率。我们发现两组之间的心源性死亡有显着差异(P <0.001),而全因死亡中没有差异(P = 0.624)。在10例中度冠状动脉疾病患者中,有1例进行了移植前冠状动脉搭桥术。在13例重症患者中,有3例接受了经皮冠状动脉介入治疗,有6例接受了冠状动脉搭桥术。总体而言,接受这两种干预措施的患者中有50%死于与心脏相关的原因,而没有接受过两种干预的患者均无死于与心脏相关的原因(P <0.0001)。我们的结论是,尽管进行了冠脉介入治疗,但死亡率仍然很高患有严重冠状动脉疾病的OLT患者。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号